(Q38068354)

28 August 2017

1 reference

title

Drug-induced liver injury in the elderly (English)

1 reference

28 August 2017

1 reference

ChEBI release 2020-05-28

Jonathan G Stine

1

1 reference

28 August 2017

Praveen Sateesh

series ordinal

2

1 reference

28 August 2017

James H Lewis

series ordinal

3

1 reference

28 August 2017

1 January 2013

1 reference

Current gastroenterology reports

28 August 2017

1 reference

28 August 2017

15

1 reference

28 August 2017

1

1 reference

28 August 2017

299

1 reference

https://scigraph.springernature.com/pub.10.1007/s11894-012-0299-8

28 August 2017

0 references

cites work

Drug metabolism and drug interactions in the elderly

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0299-8

Aging of the liver: facts and theories.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0299-8

Gastrointestinal and liver side effects of drugs in elderly patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0299-8

Drug-induced liver injury: a clinical update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0299-8

Genetic association studies in drug-induced liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0299-8

Predicting and preventing acute drug-induced liver injury: what's new in 2010?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0299-8

Updating the Beers Criteria for Potentially Inappropriate Medication Use in Older Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0299-8

Inappropriate prescribing in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0299-8

A pharmacoepidemiologic study of community-dwelling, disabled older women: Factors associated with medication use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0299-8

Herbal, prescribed, and over-the-counter drug use in older women: prevalence of drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0299-8

Phenotypic characterization of idiosyncratic drug-induced liver injury: the influence of age and sex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0299-8

Oral medications with significant hepatic metabolism at higher risk for hepatic adverse events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0299-8

Risk factors for idiosyncratic drug-induced liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0299-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0299-8

The effect of age upon liver volume and apparent liver blood flow in healthy man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0299-8

Hepatic pseudocapillarisation and atherosclerosis in ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0299-8

Drug-induced liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0299-8

Outcome and prognostic markers in severe drug-induced liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0299-8

Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0299-8

Single-center experience with drug-induced liver injury from India: causes, outcome, prognosis, and predictors of mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0299-8

Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0299-8

Drug-induced acute liver failure: results of a U.S. multicenter, prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0299-8

Epidemiology of idiosyncratic drug-induced liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0299-8

Incidence of drug-induced hepatic injuries: a French population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0299-8

Determinants of the clinical expression of amoxicillin-clavulanate hepatotoxicity: a prospective series from Spain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0299-8

Hepatic findings in long-term clinical trials of ximelagatran

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0299-8

Gone (from the Physicians' desk reference) but not forgotten: propylthiouracil-associated hepatic failure: a call for liver test monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0299-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0299-8

Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0299-8

Aging and hepatotoxicity of isoniazid and rifampin in pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0299-8

Isoniazid-associated hepatitis deaths: a review of available information

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0299-8

Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0299-8

Association of slow N-acetyltransferase 2 profile and anti-TB drug-induced hepatotoxicity in patients from Southern Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0299-8

Drug- and chemical-induced cholestasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0299-8

Outcome of liver transplantation for drug-induced acute liver failure in the United States: analysis of the United Network for Organ Sharing database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0299-8

Polypharmacy in nursing home residents in the United States: results of the 2004 National Nursing Home Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0299-8

Causality assessment of drug-induced hepatotoxicity: promises and pitfalls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0299-8

Factors associated with potentially inappropriate drug utilization in a sample of rural community-dwelling older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0299-8

Pseudocapillarization and associated energy limitation in the aged rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-012-0299-8

Diclofenac-associated hepatotoxicity: analysis of 180 cases reported to the Food and Drug Administration as adverse reactions

21 January 2018

1 reference

12 December 2020

Evaluation of risk factors for antituberculosis treatment induced hepatotoxicity

1 reference

12 December 2020

Pain and pain medication use in community-dwelling older adults

1 reference

12 December 2020

Fatal cholestatic jaundice in elderly patients taking benoxaprofen.

1 reference

12 December 2020

Causality assessment of adverse reactions to drugs--II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge

1 reference

12 December 2020

Discrepancies in reported drug use in geriatric outpatients: relevance to adverse events and drug-drug interactions

1 reference

12 December 2020

Prevalence and predictors of polypharmacy among older primary care patients in Germany

1 reference

12 December 2020

Clinical characteristics of drug-induced liver injury in the elderly

1 reference

12 December 2020

Side effects of benoxaprofen

1 reference

12 December 2020

Herbal supplement use by persons aged over 50 years in Britain: frequently used herbs, concomitant use of herbs, nutritional supplements and prescription drugs, rate of informing doctors and potential for negative interactions

1 reference

12 December 2020

1 reference

12 December 2020

Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period

1 reference

12 December 2020

Benoxaprofen: side-effect profile in 300 patients.

1 reference

12 December 2020

Drug- and chemical-induced cholestasis

1 reference

12 December 2020

The pharmacokinetics of benoxaprofen in elderly subjects

1 reference

12 December 2020

NAT2 and CYP2E1 polymorphisms and susceptibility to first-line anti-tuberculosis drug-induced hepatitis.

1 reference

12 December 2020

Alterations in the liver with ageing.

1 reference

12 December 2020

10.1007/S11894-012-0299-8

Identifiers

DOI

1 reference

Dimensions Publication ID

28 August 2017

0 references

1 reference